RE: Strange26 Mar 2018 10:22
I got mine at 7 through RNS Alert - don't know what the problem at LSE might be. Anyhow, immediate response is results good enough to keep us going, not good enough to transform sp at this stage. Losses down, but not down spectacularly. Sales of dermapure up, but not up really spectacularly. Profits up 400 per cent, but still only �2.6m.etc etc. There's some decent figures but not enough to attract the masses. Next year will let us know whether we really have a goer here. I think we do though.